Kinfo
Enovis Corporation logo

Enovis Corporation

ENOVNYSEHealthcare·US · USD
$22.52
-0.19 (-0.86%)
Live · 2026-06-29

Price

Key statistics

Valuation
Market cap1.31B USD
Enterprise value2.69B USD
Trailing P/E-1.09
Forward P/E5.44
PEG ratio0.01
Price / sales0.56
Price / book0.86
Profitability
Gross margin62.04%
Operating margin3.64%
Profit margin-49.91%
Return on assets1.09%
Return on equity-55.35%
Income (TTM)
Revenue2.28B USD
Gross profit1.39B USD
EBITDA333.87M USD
Net income-1.14B USD
Diluted EPS-$19.89
Rev. growth (YoY)5.40%
Balance sheet
Total cash33.13M USD
Total debt1.41B USD
Debt / equity95.34
Current ratio2.04
Book value / share$25.66
Cash flow (TTM)
Operating cash flow242.84M USD
Levered free cash flow206.90M USD
Shares & price
Shares outstanding57.54M
Float56.59M
Held by institutions119.73%
Beta1.49
50-day MA$23.61
200-day MA$26.12
52-week high$36.82
52-week low$20.55
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Recent payments
  • 2022-04-05$25.75
Earnings (EPS)
DateEst.ActualSurprise2026-05-070.810.89+9.88%2026-03-25-0.530.94+277.36%2026-02-260.840.95+13.10%2026-02-130.440.50+13.64%2025-11-180.250.33+32.00%
About Enovis Corporation

Enovis Corporation is a diversified healthcare equipment company focused on developing and supplying a broad range of innovative medical technology solutions. The primary function of the company is to enhance patient care and improve treatment outcomes across various medical specialties. Enovis is known for its advanced surgical solutions, rehabilitation devices, and other healthcare innovations that serve both healthcare providers and patients. The company's products cater to sectors such as orthopedics, pain management, and wound care, offering a significant impact on surgical efficiencies and patient recovery. By providing a comprehensive portfolio of medical solutions, Enovis plays a vital role in the healthcare industry, supporting the demands of hospitals, clinics, and healthcare professionals. In the financial market, Enovis Corporation holds significance as it merges cutting-edge technology with healthcare services, contributing to the advancement of medical science and the betterment of patient-centric care. Its commitment to research and development underscores its role in shaping the future of healthcare, offering both therapeutic benefits and operational efficiencies.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Damien McDonald
Employees
7,367
Headquarters
Wilmington, DE, United States

Frequently asked questions about Enovis Corporation